WNV Vaccine Announced by
Co. Linked to Giuliani
by Robert Lederman
robert.lederman@worldnet.att.net
From: FINANCIAL TIMES LONDON 8/1/2000
Peptide Therapeutics, the UK biotech company, said it had
been awarded a $3,000,000 grant to develop a new vaccine to combat
the mosquito-borne West Nile virus, which killed seven The
vaccine will be developed at OraVax, Peptide's US subsidiary,
using the company's proprietary ChimeriVax technology."[see
below for their detailed press release]
For the past 10 months I have been writing about a
bio-chemical corporation, Oravax, in relation to the so-called
WNV (West Nile Virus) epidemic in NYC. The V.P of Oravax,
Dr. Thomas Monath has been working behind the scenes with
Mayor Giuliani, former OEM chief Jerry Hauer, Dr. Cohen and
the CDC since the very beginning of this iissue.
From: Newsday 9/25/99-Deadly Discovery
"Virologist Thomas Monath, one of the country's leading
authorities on mosquito-carried viruses, called the discovery ``a
bombshell,'' and added: `` This is the biggest arbovirus story of
the last 50 years. Wow!'' Monath, who works for OraVax, a
biotechnology company in Boston, said he has been working
closely with CDC investigators in New York since the
encephalitis outbreak began in late August. He is assisting
federal scientists in trying to figure out a way to deal with the
new development."
As predicted, Oravax has now been given a grant from the
N.I.H. (National Institute of Health) to create a WNV vaccine.
The theory I and a number of other activists have been
suggesting is that the entire WNV panic has been created
specifically in order to justify the mass distribution of this very
vaccine throughout the entire U.S.
Oravax was granted a license by the U.S. Army bio-warfare lab
in Ft. Dietrick in 1996 (Monath was previously a researcher at
the same lab) to manufacture a Japanese encephalitis vaccine
derived from a genetically-altered virus the Army itself
created. WNV is a variation of Japanese encephalitis.
Numerous medical and scientific institutions, many run by the
Federal government, have been quietly experimenting with
WNV in NYC and the surrounding area for decades [see
references below]. Most of this research involved bio-warfare
applications.
According to the press release and articles below the vaccine is
a live, attenuated vaccine (it contains live WN virus) and
involves "the construction of a chimeric virus in which the
envelope genes of yellow fever vaccine are replaced with the
corresponding genes of the target West Nile virus". In other
words, the plan appears to be to expose the entire nation orally
to a genetically-modified form of WNV.
Since the vaccine is made from a genetically-altered strain
there is no way to know exactly what other theoretically
beneficial or harmful genes may have been added. Scientists in
the field of GE foods (genetically-altered foods) have already
found evidence that genes in the pollen of these foods can
become incorporated into the DNA of insects that pollinate the
GE plants. In other words it is possible to incorporate these
genes into your own DNA simply by eating the food, or in this
instance, orally taking a vaccine.
[From: biotech_activists@iatp.org "Tappeser"
Organization: Oeko-Institute e.V.
Date: Tue, 23 May 2000 15:37:25 +0100
Subject: new stories from Germany
"The German Television ZDF reported on Sunday May 21 that
a German researcher found a gene transfer from genetically
engineered rapeseed to bacteria and fungi in the gut of honey
bees. Prof. Hans-Hinrich Kaatz from the Institut für
Bienenkunde (Institute for bee research) at the University of
Jena experimented during the last three years with honey bees
on an experimental field with transgenic rapeseed in Saxony,
Germany."
Mayor Giuliani and his advisors have been massively spraying
NYC with a variety of toxic pesticides since last Fall, despite
knowing that experts in the field of mosquito control have
determined that such spraying actually increases the number of
mosquitoes, makes succeeding generations pesticide resistant
and increases the incidence of mosquitoes infected with
transmissible viruses like WNV by as much as 15 times.
see: Are Mosquito Spray Pesticides Worsening the Encephalitis Problem? http://www.chem-tox.com/brevard/index.htm
SOURCE: Journal of the American Mosquito Control Assoc,
Dec;13(4):315-25, 1997 Howard JJ, Oliver New York State
Department of Health, SUNY-College ESF, Syracuse 13210,
USA.
Also see my articles on this at
Considering the mild nature of WNV their actions appear to be
intended to increase WNV rather than to decrease it. Dr. Cohen
implied as much two days ago.
NY Post 8/1/2000-
SPRAY IT AIN'T SO!
ROUND 2 ON S.I.
"Cohen said...Part of the reason for the new skeeter woes is that
between 10 and 20 percent of the bugs won't be killed by the
pesticide [the ones that are resistant to the chemicals] - and
those that live will reproduce, Cohen said....Cohen said the
traps were nearly empty in the first two days after the initial
Staten Island spraying last month, but now they're filling up
again. "This is not unexpected," he insisted."
That Dr. Cohen acknowledges he knows that the spraying
would lead to new generations of pesticide resistant mosquitoes
supports the idea that the spraying is actually intended to help
create a demand for the vaccine, which the NYC officials
unquestionably knew was already in development and testing.
What the real purpose of the vaccine is one can only guess at
this point.
From: NY Times 8/7/98
GERM DEFENSE PLAN IN PERIL
AS ITS FLAWS ARE REVEALED.
If you carefully read the
very long article this is excerpted from you will see detailed
evidence of how Dr. Monath, former Giuliani OEM chief Jerry
Hauer, the president of Rockefeller University (where they
have experimented with WNV for decades) and Dr. J. Craig
Venter, president of The Institute for Genomic Research (the
co-researchers and co-owners of the Human Genome Project)
have been pressuring President Clinton to spend billions on a
nationwide vaccine program against germ warfare.
EXCERPT: "In April, the president...and his top officials met
at the White House on April 10 with seven private scientists in
the Truman Room, where Cabinet meetings are held. For an
hour, participants say, the scientists discussed the germ topic
and pushed for a vaccine stockpile. Clinton's attending officials
included the secretary of defense, the attorney general, the
secretary of health and human services, the director of Central
Intelligence and the president's national security adviser. The
scientists present were Dr. Frank Young, a former head of the
Food and Drug Administration, who moderated the panel; Dr.
Joshua Lederberg, president emeritus of Rockefeller
University; Dr. Lucille Shapiro, a biologist at Stanford
University; Jerome Hauer, head of emergency management for
New York City; and Dr. Barbara Rosenberg, a biological
arms-control expert at the Federation of American Scientists, a
private group. The scientific panel also had two industry
experts, both with financial ties to vaccine work. ..Dr. Thomas
Monath was identified in a White House announcement as a
vice president of OraVax and a former official of the Centers
for Disease Control and the U.S. Army Medical Research
Institute of Infectious Diseases, the government's top body for
defensive germ-warfare studies...Based in Cambridge, Mass.,
OraVax was founded in 1990 to tap an emerging
multi-billion-dollar market in oral vaccines and antibodies to
combat infectious diseases. But the small company kept having
problems getting beyond research and bringing products to
market. By 1996 and 1997, its survival at stake, OraVax tried
to win part of the Pentagon's expanding germ work as a
subcontractor to make smallpox and other vaccines. By early
this year, that work had failed to materialize and the company's
stock price was down 90 percent from $10 a share in the initial
public offering...."The way to handle it is to be open, so people
understand that I may have a potential bias,"Monath said. "I
don't make it a business of taking advantage of situations in
which I'm asked to participate to push the OraVax agenda."
From: http://info.med.yale.edu/EIINet/MonathSeminar.html
[Note how the VP of Oravax, manufacturer of the encephalitis
vaccine who is advising Giuliani on this crisis, was both a
researcher at Ft. Dietrick Bio-Warfare lab and a CDC scientist.]
"Thomas Monath is one of the world's leading arbovirologists.
He is currently Vice- President of Research and Medical
Affairs at OraVax, Inc. in Cambridge, Massachusetts. In this
position he is responsible for the scientific direction of
programs on vaccine development...Prior to this he was the
Chief of the Virology Division, U.S. Army Medical Research
Institute of Infectious Diseases at Fort Detrick in Maryland. In
this position he was responsible for the development of
genetically engineered vaccines against arthropod- borne and
hemorrhagic fever viruses. Between 1974 and 1988 he was the
Medical Director of the Division of Vector- Borne Infectious
Diseases at the Centers for Disease Control in Fort Collins,
Colorado."
Peptide Awarded Grant by NIH
to Develop West Nile Vaccine
CAMBRIDGE, England, 8/1/2000 /PRNewswire/
-- Peptide
Therapeutics Group plc (LSE: PTE.L) ("Peptide") announces
that it has been awarded a Fast-Track Small Business
Innovative Research (SBIR) grant by the US National Institutes
of Health ("NIH") to develop an important new vaccine to
prevent West Nile virus disease ("West Nile")...Fears are
growing that another outbreak could occur this year. Infected
birds and mosquitoes have been detected over a wide area from
New Jersey to Massachusetts. Public health warnings have
been issued to residents of the affected States, and intensive
mosquito control is underway in many areas. There is no
vaccine, cure or specific therapy against West Nile virus
disease. The US government is actively pursuing a campaign to
combat the disease, including funding the development of
vaccines for preventative use.
The West Nile vaccine will be developed using Peptide's
proprietary ChimeriVax(TM) technology. It will be a live,
attenuated vaccine and involves the construction of a chimeric
virus in which the envelope genes of yellow fever vaccine are
replaced with the corresponding genes of the target West Nile
virus. This approach has already been employed by Peptide to
develop vaccines against dengue fever (in pre-clinical
development) and Japanese encephalitis (due to commence
Phase I trials shortly).
Dr. Thomas Monath, Vice President Research & Medical
Affairs of Peptide, said: "The advantages of ChimeriVax(TM)
vaccines include their high safety profile, ability to induce
protection within a few days after a single dose, and
long-lasting immunity without the need for booster doses. A
ChimeriVax(TM) West Nile vaccine is therefore ideally suited
for use in an impending epidemic, where rapid immunization is
required."
Dr. John Brown, Chief Executive of Peptide, said: "We are
delighted to have been selected by the US government to
receive funding to continue to develop our West Nile vaccine.
The West Nile virus is one of the most frightening to have
emerged in recent years and there is no vaccine available to
protect against the disease. We are confident that
ChimeriVax(TM) can provide the technology to develop a
vaccine that will provide a rapid and effective solution."
For further information visit our web site at www.peptide.co.uk
.08/01/2000 11:22 EDT
http://www.prnewswire.com
See: http://www.biospace.com/
for an entire clearinghouse for bio-tech companies
Newsday 9/29/99
-Area Labs Have Long Studied Virus /
Yale, Rockefeller began tests in '50s page A28
"Epidemiologists suspect that the West Nile virus has for the
first time been isolated in humans or animals in the Western
Hemisphere, but the virus has for decades made its home in
several U.S. research laboratories, including Rockefeller
University in Manhattan and Yale University in New Haven,
Conn. In fact, investigators there were the first to grow and
study the West Nile virus in the United States. The work began
in the 1950s when unidentified viral samples from around the
world arrived at Rockefeller on a steady basis."
Newsday 5/9/2000
Mosquito From Asia Could Carry West Nile
"THE ASSOCIATED PRESS In Army tests at Fort Detrick in
Frederick, Md., japonicus was found to be the "most competent
vector"[transmittter] for West Nile virus in a laboratory
setting, when compared with other mosquitoes."
From: http://www.bioinfo.com/jev.html
[from Federal Register: March 22, 1996 (Volume 61, Number
57, Page 11812)]
DEPARTMENT OF DEFENSE
Notice of Intent To Grant an Exclusive License of a U.S.
Government-Owned Patent
Agency: U.S. Army Medical Research and Materiel Command,
DOD [Department of Defense].
Action: Notice.
Summary: In accordance with 37 CFR 404.7 (a)(I)(i),
announcement is made of the intent to grant an exclusive,
royalty-bearing, revocable license of U.S. Patent Application
Serial Number 08/348,882, filed November 28, 1994 and
entitled ``Infectious DNA Clones of Japanese Encephalitis
Virus and Attenuated Strains Japanese Encephalitis Virus
Made from the Clones'', to OraVax, Inc., 230 Albany Street,
Cambridge, Massachusetts 02139.
[Requests to the Army for further information should be
directed to the public affairs officer, Mr. Chuck Dasey (301)
619-2736]
Newsday, 10/10/99 Bugged by Spraying
"The loudest protests heard during the city's recent campaign
of insecticide spraying came from the city's tiny Green Party
and the artist-agitator Robert Lederman...Yesterday, the head
of the mayor's Office of Emergency Management, which took
the lead in the assault on the city's mosquito populace,
dismissed such concerns as "irresponsible environmental
hysteria and stupidity.""If they took a deep breath [of
Malathion?] and looked at what we did and what pains we
went through to ensure that we did it right and recognize that
human life is at stake, they'd get the perspective," said OEM
Director Jerry Hauer."
Important Note:
Mr. Lederman has explained that his articles posted here are not to be taken as official statements by the No-Spray Coalition of which he is a member or of the "No-Spray" lawsuit in which he is a plaintiff.
Blue Collar Pundit Essays
And by clicking here, you'll see an old suggestion (May 2003) of how Democrats could/should have protested the Republican convention and G.W. Bush.
This site is under construction
Click Here to Join the Discussions
in the
Blue Collar Blog!

For a great source of general tenant information,
visit the Tenant Net Home Page |

Click here to view City Limits Magazine